Vital Farms (NASDAQ:VITL) Cut to Strong Sell at Zacks Research

Zacks Research downgraded shares of Vital Farms (NASDAQ:VITLFree Report) from a hold rating to a strong sell rating in a research report sent to investors on Monday,Zacks.com reports.

Several other equities analysts have also commented on the stock. Mizuho decreased their price objective on shares of Vital Farms from $48.00 to $40.00 and set an “outperform” rating for the company in a research report on Monday. Jefferies Financial Group reiterated a “buy” rating and set a $52.00 price objective on shares of Vital Farms in a research note on Wednesday, December 17th. Weiss Ratings reissued a “hold (c+)” rating on shares of Vital Farms in a report on Monday, December 29th. Telsey Advisory Group reduced their target price on Vital Farms from $50.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Finally, BMO Capital Markets lowered their price target on Vital Farms from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Thursday, December 18th. Nine equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.00.

View Our Latest Research Report on Vital Farms

Vital Farms Stock Performance

Shares of VITL opened at $20.01 on Monday. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01. The firm has a market cap of $896.45 million, a PE ratio of 13.90 and a beta of 1.14. Vital Farms has a 12 month low of $19.75 and a 12 month high of $53.13. The stock has a fifty day moving average price of $27.85 and a 200-day moving average price of $35.48.

Vital Farms (NASDAQ:VITLGet Free Report) last announced its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The business had revenue of $213.55 million for the quarter, compared to analysts’ expectations of $212.83 million. During the same quarter last year, the firm earned $0.23 earnings per share. The firm’s quarterly revenue was up 28.6% compared to the same quarter last year. Equities research analysts predict that Vital Farms will post 1.11 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Russell Diez-Canseco sold 16,734 shares of the company’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $35.05, for a total value of $586,526.70. Following the sale, the chief executive officer owned 649,684 shares in the company, valued at $22,771,424.20. This represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Matthew Ohayer sold 25,000 shares of the firm’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $30.85, for a total value of $771,250.00. Following the sale, the insider directly owned 6,361,190 shares in the company, valued at approximately $196,242,711.50. This trade represents a 0.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 86,734 shares of company stock valued at $2,498,827. Insiders own 21.30% of the company’s stock.

Hedge Funds Weigh In On Vital Farms

Several institutional investors have recently made changes to their positions in the company. Triumph Capital Management purchased a new stake in Vital Farms during the fourth quarter worth $25,000. Quarry LP acquired a new position in shares of Vital Farms in the fourth quarter worth about $27,000. Exchange Traded Concepts LLC acquired a new stake in shares of Vital Farms during the 3rd quarter valued at about $28,000. Global Retirement Partners LLC grew its position in shares of Vital Farms by 4,382.6% during the 4th quarter. Global Retirement Partners LLC now owns 1,031 shares of the company’s stock valued at $33,000 after acquiring an additional 1,008 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in shares of Vital Farms by 225.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,452 shares of the company’s stock valued at $46,000 after purchasing an additional 1,006 shares in the last quarter. 98.59% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

  • Positive Sentiment: Analysts’ consensus still shows some support — a recent aggregator noted a “Moderate Buy” consensus from analysts, which could provide buying interest if sentiment stabilizes. Analyst Consensus: Moderate Buy
  • Positive Sentiment: Some Wall Street commentary highlights bulls and reasons to consider the stock, which may attract opportunistic investors if shares overshoot to the downside. Wall Street Bulls Look Optimistic
  • Neutral Sentiment: Insider transaction — major shareholder Matthew Ohayer sold 20,000 shares at about $20.33 (≈$406.6K). The sale is small relative to his ~6.32M share holding (≈0.32% reduction), so it’s a modest signal rather than a large forced liquidation. SEC Filing: Insider Sale
  • Negative Sentiment: Rosen Law Firm announced a securities‑class‑action investigation alleging Vital Farms may have provided materially misleading information to investors — such probes can increase legal risk, potential liabilities and near‑term headline volatility. Rosen Law Firm Investigation
  • Negative Sentiment: Zacks Research downgraded Vital Farms from “Hold” to “Strong Sell,” which can accelerate outflows from model‑based funds and momentum traders. Zacks Downgrade
  • Negative Sentiment: Broker downgrades and lowered forecasts — Needham and Mizuho have reduced expectations for Vital Farms, and Benchmark cut to Hold and removed its price target after the company issued a “volatile” Q1 outlook. These analyst moves increase sell‑side pressure and signal uncertainty around near‑term revenue/earnings momentum. Needham Outlook
  • Negative Sentiment: Mizuho lowered expectations as well, compounding the negative analyst trend and likely contributing to shorter‑term downside. Mizuho Lowers Expectations
  • Negative Sentiment: Benchmark’s downgrade tied to a cautious Q1 outlook — the firm cited tempered FY26 revenue growth and removed its price target, reinforcing recessionary/volume risk concerns that can pressure valuation multiples. Benchmark Downgrade

Vital Farms Company Profile

(Get Free Report)

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.

Featured Stories

Analyst Recommendations for Vital Farms (NASDAQ:VITL)

Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.